Morgan Stanley keeps Clearway Energy at Overweight but cuts price target
Morgan Stanley kept its Overweight rating on Clearway Energy and cut its price target to $52.00 from $58.00, according to Dow Jones Newswires.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Morgan Stanley kept its Overweight rating on Clearway Energy, according to Dow Jones Newswires, which cited Benzinga ratings data. The bank also lowered its price target for the stock to $52.00 per share from $58.00.
why it matters
Analyst rating changes of this kind usually affect the company's own stock more than the wider market. A lower target with an unchanged positive call signals a smaller expected upside, while the overall analyst view remains favorable.
tags
instruments
sources
- BioMarin Pharmaceutical Is Maintained at Overweight by Morgan Stanley — Dow Jones Newswires, 21 October 2026 at 16:06 UTC
- Clearway Energy Is Maintained at Overweight by Morgan Stanley — Dow Jones Newswires, 21 October 2026 at 16:20 UTC
- DT Midstream Is Maintained at Overweight by Morgan Stanley — Dow Jones Newswires, 21 October 2026 at 16:29 UTC
- FirstEnergy Is Maintained at Overweight by Morgan Stanley — Dow Jones Newswires, 21 October 2026 at 16:36 UTC
- Netflix Is Maintained at Overweight by Morgan Stanley — Dow Jones Newswires, 21 October 2026 at 16:44 UTC
- Jazz Pharmaceuticals Is Maintained at Overweight by Morgan Stanley — Dow Jones Newswires, 21 October 2026 at 16:40 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗